A Houston startup has created a web tool for tracking the coronavirus. Pexels

A Houston tech startup has created a web application to give the residents of Harris County all the local information on COVID-19 in the palm of their hand.

Predictive Solutions uses a map tool to indicate the county's nearby testing locations as well as cases that have been self reported in the area through the tool. While not trying to be comprehensive, the website is trying to track trends with the disease.

"We developed the app to help streamline communication between the City of Houston, the healthcare community, aid organizations and Harris County residents, while mitigating the logistical nightmare of making sure presumed cases get tested," says Stewart Severino, co-founder and CEO of Predictive Solutions, in the news release.

While the web app is something consumers can use and report on, it's also something that federal, state and local officials can use as a data solution to predicting the virus' trends.

"By providing a mechanism for the city to monitor testing locations and enabling users to self-report symptoms, Predictive hopes to deliver a platform that can help officials gain a firm handle on the trending virus, allowing for decision-making that's directly informed by data," says Predictive's co-founder and CTO, Theo Patestos, in the release.

The startup is a portfolio company of H Town Incubator, a new coworking space in town that provides its members with services like health care and legal counsel. The app can be accessed online through desktop or mobile.

"This is only a starting point for presenting the data," says Severino, who's also the CEO of H Town Incubator. "We need city and state officials, as well as the public to help make this application useful. The app is only as good as the data it gathers."

A new coworking space plans to debut on Houston's northside. Photo courtesy of H-Town Incubator

Houston coworking concept to launch to arm members with advisers and health insurance options

new to hou

Freelancers and small business owners might not miss the office politics or mandatory training seminars, but there are quite a few things like mentorship and health insurance that most coworking spaces don't provide. A new Houston company hopes to fill the void.

H-Town Incubator is a 30,000-square-foot coworking space on the northside of town with plans to launch officially in January. The space has desk, cubicle, or office membership options, but also provides its members with advisory services, like legal, accounting, marketing, and more.

"What if an entrepreneur, freelancer, or contractor were given access to an hour or so for a month with legal or accounting," says Stewart Severino, CEO of H-Town Incubator. "You have that real coaching available to you."

Another unprecedented perk is that entrepreneurs can have access to affordable health insurance for as low as $60 a month. Severino says that small businesses can even white label this plan so that their team can have their ID cards labeled with their company's information.

"There are so many underinsured and uninsured people and families out there. It's a big deal," Severino tells InnovationMap. "Because of the co-op we have with our insurance partners, we can put together our own plan and offer that to these individuals."

At this point, about 15,000 square feet of space built out with space for 80 to 100 coworkers to work out of 55 cubicles, 30 offices, and other desk space. The second half of the floor could also be developed for additional offices, desks, and cubicles. The space also has two kitchens and conference rooms that Severino says members won't have any limitations on access, like other models that use credit systems.

"Because we're smaller, we can do that," he says. "We don't have to go that route of being too structured."

With easy access to Bush Intercontinental Airport and neighboring communities like The Woodlands and Spring, Severino says he's already seen both local and international opportunities.

Severino says the idea for the space came organically. He was working out of this office and saw connections happening between various industries. That's how he got the idea to build it into coworking space.

With his 20-year marketing career, Severino says he's seen the smoke and mirrors of "dressed-up" coworking spaces on the market today, he wants to provide something deeper for entrepreneurs.

"When things lack substance, that really bothers me on a personal level," he says. "I want to go out and create something that can serve the individual as a whole."

H-Town Incubator will celebrate a grand opening in mid January, but Severino plans to offer free drop-in days for entrepreneurs to take a trial run. Ultimately, Severino hopes the initiative becomes a collaborative space for companies of all phases and industries to work as resources for each other.

"It will be a dynamic place for sure," he says, adding that he expects to add programming to the mix too.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."